Onex Newswire

Onex Newswire

Comprehensive Real-Time News Feed for Onex.

Results 1 - 20 of 104 in Onex

  1. Zacks Investment Research Upgrades OncoCyte (OCX) to HoldRead the original story w/Photo

    Monday Apr 16 | AmericanBankingNews.com

    According to Zacks, "OncoCyte Corporation is primarily focused on the development of novel, non-invasive blood and urine diagnostic tests for detection of cancer. OncoCyte Corporation is based in Alameda, California.

    Comment?

  2. Onex (ONEX) Lowered to Sector Perform at Royal Bank of CanadaRead the original story w/Photo

    Monday Apr 16 | AmericanBankingNews.com

    ... research analysts have also recently weighed in on the company. Canaccord Genuity increased their price objective on Onex from C$108.00 to C$111.00 and gave the company a "buy" rating in a research report on Monday, May 15th. Scotiabank reissued an ...

    Comment?

  3. Vista Equity to merge PowerSchool, PeopleAdmin with Onex investment-sourcesRead the original story w/Photo

    Monday Apr 16 | Reuters

    Private equity firm Vista Equity Partners Management LLC has agreed to merge two education technology firms it owns, PowerSchool and PeopleAdmin, with an investment from buyout firm Onex Corp , for $350 million in 2015 from Pearson Plc . It has since spent more than $1 billion on PowerSchool acquiring eight other companies, including SunGard's public sector and education business last year.

    Comment?

  4. Short Interest in OncoCyte (OCX) Rises By 5.9%Read the original story w/Photo

    Tuesday Apr 10 | AmericanBankingNews.com

    OncoCyte was the target of a large increase in short interest in the month of March. As of March 29th, there was short interest totalling 854,481 shares, an increase of 5.9% from the March 15th total of 807,018 shares.

    Comment?

  5. ONEX Co. (ONEX) to Issue $0.08 Quarterly DividendRead the original story w/Photo

    Wednesday Apr 4 | IntersportsWire

    ONEX Co. declared a quarterly dividend on Monday, April 9th, TickerTech reports.

    Comment?

  6. OncoCyte (OCX) Issues Earnings ResultsRead the original story w/Photo

    Tuesday Apr 3 | IntersportsWire

    OncoCyte released its earnings results on Monday. The biotechnology company reported earnings per share for the quarter, meeting analysts' consensus estimates of , Bloomberg Earnings reports.

    Comment?

  7. OncoCyte (OCX) Posts Quarterly Earnings Results, Hits EstimatesRead the original story w/Photo

    Tuesday Apr 3 | Daily Political

    OncoCyte released its earnings results on Monday. The biotechnology company reported earnings per share for the quarter, meeting the consensus estimate of , Bloomberg Earnings reports.

    Comment?

  8. ONEX Co. (ONEX) Receives Consensus Rating of "Buy" from AnalystsRead the original story w/Photo

    Saturday Mar 31 | AmericanBankingNews.com

    ONEX Co. has earned a consensus rating of "Buy" from the five research firms that are covering the stock, MarketBeat Ratings reports.

    Comment?

  9. Zacks Investment Research Downgrades OncoCyte (OCX) to HoldRead the original story w/Photo

    Saturday Mar 31 | Daily Political

    According to Zacks, "OncoCyte Corporation is primarily focused on the development of novel, non-invasive blood and urine diagnostic tests for detection of cancer. OncoCyte Corporation is based in Alameda, California.

    Comment?

  10. OncoCyte Corp (OCX) Major Shareholder Purchases $5,000,000.04 in StockRead the original story w/Photo

    Friday Mar 30 | AmericanBankingNews.com

    OncoCyte Corp major shareholder Broadwood Partners, L.P. acquired 3,968,254 shares of OncoCyte stock in a transaction dated Wednesday, March 28th. The shares were bought at an average cost of $1.26 per share, for a total transaction of $5,000,000.04.

    Comment?

  11. OncoCyte (OCX) Cut to Hold at Zacks Investment ResearchRead the original story w/Photo

    Friday Mar 30 | AmericanBankingNews.com

    According to Zacks, "OncoCyte Corporation is primarily focused on the development of novel, non-invasive blood and urine diagnostic tests for detection of cancer. OncoCyte Corporation is based in Alameda, California.

    Comment?

  12. Axovant Sciences Ltd. (Axon) Reaches $1.33 52-Week Low; Onex Sub...Read the original story w/Photo

    Friday Mar 30 | Hill Country Times

    Axovant Sciences Ltd. Reaches $1.33 52-Week Low; ONEX SUB VOTING SHARES CANADA Shorts Raised By 9.56% ONEX CORP SUB VOTING SHARES CANADA had an increase of 9.56% in short interest. ONEXF's SI was 203,900 shares in March as released by FINRA.

    Comment?

  13. OncoCyte (OCX) Stock Rating Lowered by Zacks Investment ResearchRead the original story w/Photo

    Friday Mar 30 | IntersportsWire

    According to Zacks, "OncoCyte Corporation is primarily focused on the development of novel, non-invasive blood and urine diagnostic tests for detection of cancer. OncoCyte Corporation is based in Alameda, California.

    Comment?

  14. OncoCyte (OCX) Upgraded by Zacks Investment Research to BuyRead the original story w/Photo

    Thursday Mar 29 | IntersportsWire

    Zacks Investment Research currently has $1.50 price objective on the biotechnology company's stock. According to Zacks, "OncoCyte Corporation is primarily focused on the development of novel, non-invasive blood and urine diagnostic tests for detection of cancer.

    Comment?

  15. OncoCyte Corp (OCX) Short Interest UpdateRead the original story w/Photo

    Monday Mar 26 | The Breeze

    OncoCyte Corp was the target of a significant increase in short interest in the month of March. As of March 15th, there was short interest totalling 807,018 shares, an increase of 9.2% from the February 28th total of 738,822 shares.

    Comment?

  16. OncoCyte Corp (OCX) Sees Large Increase in Short InterestRead the original story w/Photo

    Monday Mar 26 | AmericanBankingNews.com

    OncoCyte Corp was the target of a large growth in short interest in March. As of March 15th, there was short interest totalling 807,018 shares, a growth of 9.2% from the February 28th total of 738,822 shares.

    Comment?

  17. Janney Montgomery Scott Downgrades OncoCyte (OCX) to NeutralRead the original story w/Photo

    Mar 25, 2018 | IntersportsWire

    Separately, Zacks Investment Research lowered shares of OncoCyte from a buy rating to a hold rating in a research note on Tuesday, January 9th. Shares of OCX stock opened at $1.35 on Wednesday.

    Comment?

  18. Wednesday Sector Laggards: Food, DiagnosticsRead the original story

    Mar 21, 2018 | MarketNewsVideo

    In trading on Wednesday, food shares were relative laggards, down on the day by about 1.5%. Helping drag down the group were shares of General Mills , down about 8% and shares of Kellogg Company off about 3.7% on the day.

    Comment?

  19. AirAsia to sell 182 Airbus jetliners in $1.2B dealRead the original story w/Photo

    Feb 28, 2018 | MarketWatch

    ... Airbus jets and sell a 10% stake in the company to Air Asia, assuming options on 20 yet-to-be-delivered A320neo planes. Onex Corp., a Canadian asset manager, will also inject fresh equity into Fly Leasing, boosting its stake to 17%. BBAM manages Fly ...

    Comment?

  20. Recent Analysts' Ratings Updates for ONEXRead the original story w/Photo

    Feb 28, 2018 | Daily Political

    They now have a "sector perform" rating on the stock. 2/26/2018 - ONEX had its price target raised by analysts at Royal Bank of Canada from C$103.00 to C$105.00.

    Comment?